Latest Episodes
Perseverance pays off – Looking beyond the obvious mutations in NSCLC
Why is it important to perform comprehensive molecular testing in non-small cell lung cancer to look beyond the obvious mutations? Which biomarker tests are...
Ovarian cancer: Pre-analytical phase challenges and biomarker testing
What are the common pre-analytical phase challenges in ovarian cancer, and how can we overcome them? Why is it important to identify genetic alterations? ...
Lung cancer: Pre-analytical phase challenges and biomarker testing
What are the common pre-analytical phase challenges in lung cancer, and how can we overcome them? Why is it important to identify genetic alterations?...
Treatment optimization in mCRC: third-line and beyond
Treatment of advanced colorectal cancer should be considered a continuum of care and patients should be offered as many life prolonging therapies as possible. ...
Precision oncology: An overview of tumour agnostic therapies
What are tumour agnostic cancer treatments and which biomarkers do they target? Join Prof. David Hong (Medical Oncologist at MD Anderson Cancer Center, Houston,...
Prostate Cancer: Pre-Analytical Phase Challenges and Biomarker Testing
What are the common pre-analytical phase challenges in prostate cancer, and how can we overcome them? Why is it important to identify genetic alterations?...